Scientists measured levels of beta-amyloid (Aβ40, Aβ42), pTau-181, NfL, and glial fibrillary acidic protein (GFAP), which are all markers of Alzheimer’s disease. They also assessed the brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback